Related Experiment Video
Updated: Jan 17, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Relationship between Meteorin-like protein and type 2 diabetes mellitus: an update and meta-analysis
Jing Xie1, Yanhua Jiang2, Jiayi Yao1
1Department of Endocrinology, First Affiliated Hospital of Soochow University, Suzhou, P.R. China.
Background:
Meteorin-like protein (Metrnl) is considered a novel adipokine, which plays an important role in the occurrence and development of type 2 diabetes mellitus (T2DM). In a previous meta-analysis, no significant difference in circulating Metrnl levels was found between T2DM patients and normal glucose tolerance individuals. However, these meta-analyses included limited studies, and more studies about Metrnl and T2DM were published recently. Therefore, the association between Metrnl and T2DM remains uncertain.
Aim:
This study aimed to systematically and comprehensively update the relationship between circulating Metrnl levels and T2DM.
Methods:
A systematic search was conducted on the Web of Science, Wiley Online Library, PubMed, and Ovid databases using the terms 'type 2 diabetes mellitus' in combination with 'Metrnl'. Meta-analysis results were reported as standardized mean differences (SMDs) with corresponding 95% confidence intervals (CIs).
Results:
In total, 17 studies, including 649 patients with T2DM and 396 healthy controls, were included in the meta-analysis. We found that circulating Metrnl levels were lower in patients with T2DM than in healthy individuals (SMD: -0.47, 95% CI: (-0.98, 0.05); prediction interval: (-3.66, 2.73)). Moreover, serum Metrnl levels in patients with T2DM were significantly lower than in healthy individuals (SMD: -0.91, 95% CI: (-1.60, -0.22); prediction interval: (-5.03, 3.21)).
Conclusions:
This study aimed to systematically and comprehensively update the relationship between circulating Metrnl levels and T2DM. A clearer understanding of the role of Metrnl in T2DM could facilitate the development of effective treatments.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer
Oral Hypoglycemic Agents: Biguanides and Glitazones

